Abstract

BackgroundUrinary liver-type fatty acid-binding protein (L-FABP) is a well-known marker of proximal tubular impairment. We evaluated the relationship between cardiovascular disease (CVD) risk factors and levels of L-FABP in a cross-sectional community-based study. Participants with normoalbuminuria and normal estimated glomerular filtration rate (eGFR), that is, non-chronic kidney disease (non-CKD), were enrolled in this study. To the best of our knowledge, this is the first study to focus on the association between CVD risk factors and a proximal tubular marker in the Japanese general population with normoalbuminuria and normal eGFR.MethodsThe present study is part of the Sasayama study. The participants included 1000 community residents (447 men and 553 women) aged 40–64 years without a history of CVD or renal dysfunction. Out of these participants 375 men and 477 women, defined as non-CKD, were included for further analysis. In each sex, the highest quintile group was considered to have high-normal L-FABP levels. A multiple logistic regression model was used to evaluate the relationship between risk factors for CVD and high-normal L-FABP levels in the non-CKD participants. We performed a similar analysis using the high-normal urinary albumin to creatinine ratio (UACR) as a dependent variable instead of L-FABP.ResultsAmong the non-CKD participants, in the highest quintile group (Q5, top 20%), L-FABP was ≥2.17 μg/gCre in men and ≥ 2.83 μg/gCre in women. In women, the multivariate odds ratio was 3.62 (1.45–9.00) for high-normal L-FABP in the presence of diabetes mellitus (DM) compared with that in the group without DM. However, the relationship between DM and the UACR level was not significant. In men, DM was significantly associated with high-normal UACR. However, the relationship with L-FABP levels was not significant.ConclusionsThe presence of DM was more strongly related to high-normal L-FABP levels than to high-normal UACR in women even at the stage of normoalbuminuria and normal eGFR. Our results were also consistent with the findings of a previous study where women were more prone to nonalbuminuric renal impairment compared to men, although further studies are required to confirm the results.

Highlights

  • Urinary liver-type fatty acid-binding protein (L-FABP) is a well-known marker of proximal tubular impairment

  • L-FABP levels were significantly higher in the groups with normal estimated glomerular filtration rate (eGFR) and albuminuria than in other groups, while there was no significant difference in women

  • In both men and women, the group with normal eGFR and albuminuria had the highest levels of variables regarding diabetes mellitus (DM)

Read more

Summary

Introduction

Urinary liver-type fatty acid-binding protein (L-FABP) is a well-known marker of proximal tubular impairment. Participants with normoalbuminuria and normal estimated glomerular filtration rate (eGFR), that is, non-chronic kidney disease (non-CKD), were enrolled in this study. To the best of our knowledge, this is the first study to focus on the association between CVD risk factors and a proximal tubular marker in the Japanese general population with normoalbuminuria and normal eGFR. Chronic kidney disease (CKD) progresses to endstage renal disease (ESRD) and represents an independent risk factor for cardiovascular disease (CVD) [1,2,3]. For diagnosis of CKD, estimated glomerular filtration rate (eGFR), urine total protein, and urine albumin are usually measured during medical check-ups or in clinical settings [4]. We estimate that there is a considerable proportion of patients with early-stage renal impairment that is not detected by eGFR and urinary albumin. An easy-to-use marker for proximal tubules may facilitate diagnosis of these asymptomatic patients more definitively

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call